| An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models B Schepens, L van Schie, W Nerinckx, K Roose, W Van Breedam, ... Science Translational Medicine 13 (621), eabi7826, 2021 | 57 | 2021 |
| OPENPichia: licence-free Komagataella phaffii chassis strains and toolkit for protein expression K Claes, D Van Herpe, R Vanluchene, C Roels, B Van Moer, E Wyseure, ... Nature Microbiology 9 (3), 864-876, 2024 | 12* | 2024 |
| Massively parallel interrogation of protein fragment secretability using SECRiFY reveals features influencing secretory system transit M Boone, P Ramasamy, J Zuallaert, R Bouwmeester, B Van Moer, ... Nature Communications 12 (1), 1-16, 2021 | 6 | 2021 |
| Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted DD Acar, W Witkowski, M Wejda, R Wei, T Desmet, B Schepens, ... eBioMedicine 100, 2024 | 4 | 2024 |
| Pan-specific corona virus binders B Schepens, L Van Schie, H Eeckhaut, W Nerinckx, D Fijalkowska, ... US Patent App. 18/559,915, 2024 | | 2024 |
| Massively parallel analysis of protein libraries using yeast surface display H Eeckhaut Ghent University, 2024 | | 2024 |
| Yeast-based production platform for potent and stable heavy chain-only antibodies C Lonigro, H Eeckhaut, RA Symakani, K Roose, B Schepens, K Sedeyn, ... bioRxiv, 2024.03. 04.580093, 2024 | | 2024 |
| Corona virus binders B Schepens, X Saelens, N Callewaert, D DE VLIEGER, L VAN SCHIE, ... | | 2022 |